Nitschke, Yvonne
Yan, Yan
Buers, Insa
Kintziger, Kristina
Askew, Kim
Rutsch, Frank
Article History
Received: 8 May 2018
Revised: 8 May 2018
Accepted: 12 July 2018
First Online: 29 October 2018
Conflict of interest
: Y.Y. and K.A. were employees of Alexion Pharmaceuticals, Inc. at the time of the study. The company holds a patent on recombinant ENPP1-Fc. The remaining authors declare that they have no conflict of interest.